Flavonoids Luteolin and Quercetin Inhibit RPS19 and Contributes to Metastasis of Cancer Cells Through C-Myc Reduction

Overview

Journal J Food Drug Anal

Specialties Nutritional Sciences
Pharmacology
Toxicology

Date 2018 Jul 7

PMID 29976410

Citations 28

Authors

Ku-Chung Chen

Wen-Hsien Hsu

Jhih-Yun Ho

Cheng-Wei Lin

Cheng-Ying Chu

Chithan C Kandaswami

Ming-Ting Lee

Chia-Hsiung Cheng

Affiliations

Soon will be listed here.

Abstract

Flavonoids luteolin and quercetin can inhibit growth and metastasis of cancer cells. In our previous report, luteolin and quercetin was shown to block Akt/mTOR/c-Myc signaling. Here, we found luteolin and quercetin reduced protein level and transactivation activity of RPS19 in A431-III cells, which is isolated from parental A431 (A431-P) cell line. Further investigation the inhibitory mechanism of luteolin and quercetin on RPS19, we found c-Myc binding sites on RPS19 promoter. The Akt inhibitor LY294002, mTOR inhibitor rapamycin and c-Myc inhibitor 10058-F4 significantly suppressed RPS19 expression and transactivation activities. Overexpression and knockdown of c-Myc in cancer cells show RPS19 expression was regulated by c-Myc. Furthermore, Knockdown and overexpression of RPS19 was used to analyze of the function of RPS19 in cancer cells. The epithelial-mesenchymal transition (EMT) markers and metastasis abilities of cancer cells were also regulated by RPS19. These data suggest that luteolin and quercetin might inhibit metastasis of cancer cells by blocking Akt/mTOR/c-Myc signaling pathway to suppress RPS19-activated EMT signaling.

Citing Articles

Mechanistic exploration and experimental validation of the Xiaochaihu decoction for the treatment of breast cancer by network pharmacology.

Liu Q, Luo Z, Sun M, Li W, Liu S Aging (Albany NY). 2024; 16(9):7979-7999.

PMID: 38742934 PMC: 11132012. DOI: 10.18632/aging.205798.

Integrating spatial and single-cell transcriptomics reveals tumor heterogeneity and intercellular networks in colorectal cancer.

Xiao J, Yu X, Meng F, Zhang Y, Zhou W, Ren Y Cell Death Dis. 2024; 15(5):326.

PMID: 38729966 PMC: 11087651. DOI: 10.1038/s41419-024-06598-6.

Potentials of ribosomopathy gene as pharmaceutical targets for cancer treatment.

Wang M, Vulcano S, Xu C, Xie R, Peng W, Wang J J Pharm Anal. 2024; 14(3):308-320.

PMID: 38618250 PMC: 11010632. DOI: 10.1016/j.jpha.2023.10.001.

Synthesis, characterization, and efficacy evaluation of a PH-responsive Fe-MOF@GO composite drug delivery system for the treating colorectal cancer.

Shen J, Xue S, Mei Z, Li T, Li H, Zhuang X Heliyon. 2024; 10(6):e28066.

PMID: 38524612 PMC: 10957435. DOI: 10.1016/j.heliyon.2024.e28066.

Diverse roles of UBE2S in cancer and therapy resistance: Biological functions and mechanisms.

Zhang M, Wang J, Zhang Z, Guo Y, Lou X, Zhang L Heliyon. 2024; 10(2):e24465.

PMID: 38312603 PMC: 10834827. DOI: 10.1016/j.heliyon.2024.e24465.

References

Wang Q, Yang C, Zhou J, Wang X, Wu M, Liu Z . Cloning and characterization of full-length human ribosomal protein L15 cDNA which was overexpressed in esophageal cancer. Gene. 2001; 263(1-2):205-9. DOI: 10.1016/s0378-1119(00)00570-9. View

Kalidindi N, Thimmaiah N, Jagadeesh N, Nandeep R, Swetha S, Kalidindi B . Antifungal and antioxidant activities of organic and aqueous extracts of Annona squamosa Linn. leaves. J Food Drug Anal. 2017; 23(4):795-802. PMC: 9345450. DOI: 10.1016/j.jfda.2015.04.012. View

Lee L, Huang Y, Hwang J, Lee P, Ke F, Nair M . Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res. 2002; 22(3):1615-27. View

Kao W, Lin C, Lee L, Lee P, Hung C, Lin Y . Investigation of MMP-2 and -9 in a highly invasive A431 tumor cell sub-line selected from a Boyden chamber assay. Anticancer Res. 2008; 28(4B):2109-20. View

Batra P, Sharma A . Anti-cancer potential of flavonoids: recent trends and future perspectives. 3 Biotech. 2017; 3(6):439-459. PMC: 3824783. DOI: 10.1007/s13205-013-0117-5. View

Do Q, Angkawijaya A, Tran-Nguyen P, Huynh L, Soetaredjo F, Ismadji S . Effect of extraction solvent on total phenol content, total flavonoid content, and antioxidant activity of Limnophila aromatica. J Food Drug Anal. 2017; 22(3):296-302. PMC: 9354875. DOI: 10.1016/j.jfda.2013.11.001. View

Sun X, Sun K, Zheng Z, Hao D, Fu W, Xu H . Analysis of gene expression profiles for distinct stages of intestinal-type gastric cancer using suppression subtractive hybridization and cDNA microarray. Scand J Gastroenterol. 2005; 40(10):1244-5. DOI: 10.1080/00365520500206426. View

Yang K, Lamprecht S, Liu Y, Shinozaki H, Fan K, Leung D . Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. Carcinogenesis. 2000; 21(9):1655-60. DOI: 10.1093/carcin/21.9.1655. View

Liu L, Zhang J, Yang X, Fang C, Xu H, Xi X . SALL4 as an Epithelial-Mesenchymal Transition and Drug Resistance Inducer through the Regulation of c-Myc in Endometrial Cancer. PLoS One. 2015; 10(9):e0138515. PMC: 4583418. DOI: 10.1371/journal.pone.0138515. View

10.

Weng C, Yen G . Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities. Cancer Metastasis Rev. 2012; 31(1-2):323-51. DOI: 10.1007/s10555-012-9347-y. View

11.

Kreunin P, Yoo C, Urquidi V, Lubman D, Goodison S . Differential expression of ribosomal proteins in a human metastasis model identified by coupling 2-D liquid chromatography and mass spectrometry. Cancer Genomics Proteomics. 2007; 4(5):329-39. PMC: 3426217. View

12.

Lin T, Hsu W, Tsai P, Huang Y, Lin C, Chen K . Dietary flavonoids, luteolin and quercetin, inhibit invasion of cervical cancer by reduction of UBE2S through epithelial-mesenchymal transition signaling. Food Funct. 2017; 8(4):1558-1568. DOI: 10.1039/c6fo00551a. View

13.

Ferriola P, Cody V, MIDDLETON Jr E . Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol. 1989; 38(10):1617-24. DOI: 10.1016/0006-2952(89)90309-2. View

14.

Engida A, Faika S, Nguyen-Thi B, Ju Y . Analysis of major antioxidants from extracts of Myrmecodia pendans by UV/visible spectrophotometer, liquid chromatography/tandem mass spectrometry, and high-performance liquid chromatography/UV techniques. J Food Drug Anal. 2017; 23(2):303-309. PMC: 9351773. DOI: 10.1016/j.jfda.2014.07.005. View

15.

Kobayashi T, Sasaki Y, Oshima Y, Yamamoto H, Mita H, Suzuki H . Activation of the ribosomal protein L13 gene in human gastrointestinal cancer. Int J Mol Med. 2006; 18(1):161-70. View

16.

Deng S, Xing T, Zhou H, Xiong R, Lu Y, Wen B . Comparative proteome analysis of breast cancer and adjacent normal breast tissues in human. Genomics Proteomics Bioinformatics. 2006; 4(3):165-72. PMC: 5054074. DOI: 10.1016/S1672-0229(06)60029-6. View

17.

Taliou A, Zintzaras E, Lykouras L, Francis K . An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders. Clin Ther. 2013; 35(5):592-602. DOI: 10.1016/j.clinthera.2013.04.006. View

18.

Cheng C, Chen G, Yeh M, Chu C, Hsu Y, Hwang P . Expression and characterization of the JAK kinase and STAT protein from brine shrimp, Artemia franciscana. Fish Shellfish Immunol. 2010; 28(5-6):774-82. DOI: 10.1016/j.fsi.2010.01.022. View

19.

van Riggelen J, Yetil A, Felsher D . MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer. 2010; 10(4):301-9. DOI: 10.1038/nrc2819. View

20.

Luft F . The rise of a ribosomopathy and increased cancer risk. J Mol Med (Berl). 2009; 88(1):1-3. DOI: 10.1007/s00109-009-0570-0. View